Natco Pharma Ltd and Hetero Healthcare the two Indian pharmaceutical companies have launched generic Epclusa Sofosbuvir+Velpatasvir for Hepatitis C treatment.
Velpanat and Velasof medicine:
Natco Pharma and Hetero healthcare are the leading pharmaceutical companies in India. On May 2017, Both companies announced that they have received approval from Drug Controller General of India (DCGI) to make generic version of a hepatitis C drug Sofosbuvir and Velpatasvir combination tablets used for the treatment of Hepatitis C virus for the adults of all genotype 1, 2, 3, 4, 5 and 6
This fixed-dose combination Sofosbuvir and Velpatasvir had got approved from US FDA to treat patients who have Hepatitis C chronic virus with all genotype. This is sold by Gilead Sciences Inc globally under the name of Epclusa.
The drug “Sofosbuvir+Velpatasvir” has been disturbed in the market. Natco pharma Ltd manufacture and market this medicine with the name of Velpanat Velpatasvir 100 mg and Sofosbuvir 400 mg whereas Hetero launched this medicine with the name of “Velasof” brand name. Sofosbuvir and Velpatasvir is a fixed- dose combination which contains Sofosbuvir 400mg and Velpatasvir 100g as one tablet to cure Hepatitis C infection and it sold in a bottle with packing of 28 tablets.
Important points regarding (Sofosbuvir / Velpatasvir)
Velasof or Velpanat (Sofosbuvir 400mg + Velpatasvir 100mg) has nucleotide polymerase that plays the foremost responsibility in curing Hepatitis C chronic virus. It is important to take this medicine as per doctor guidelines. This tablet containing viral NS5A-inhibitor
Hepatitis C chronic virus may cause serious liver problem such as liver cancer. Taking Velasof or Velpanat tablet daily may stop the virus to spread in the body. You should store the medicine under 30°C. Before using this medicine we recommend to talk to the doctor.
Doctor consultation
Discuss with your doctor the following points. Before taking this medicine tell to doctor if you have any of these problems
- Hepatitis B past history
- HIV
- Kidney disease
- If the patient is pregnant tell the doctor because this medicine may harm your unborn baby
- If the patient is breastfeeding tell the doctor.
Dosage for Velpanat or Velasof
Take medicine exactly as your doctor prescribes
Velpanat (Sofosbuvir 400 mg + Velpatasvir 100 mg) take one tablet daily. You can take this tablet while having food. Take the tablets as prescribed by the doctor. Don’t take a tablet for smaller or larger quantities or for the longer duration than recommended by your doctor. Take the medicine on daily basis at the same time.
It is highly recommended to consult the doctor before taking the dosage. After taking medicine if you have any allergies you should consult the doctor immediately. The doctor will diagnose the patient.
Side effects of using Velasof/ Velpanat medicine:
Side Effects of using Velasof or Velpanat tablet can vary from patient to patient. If the patient is allergic after using the Velpanat or Velasof medicine it is important to take patient to hepatologist.
Call the doctor immediately if the patients have any of these side effects
- Heartbeat becomes slow
- Pale skin
- Weakness
- Chest pain
The patient may get the side effect of using this Velasof/ Velpanat tablet is headache and tiredness/ fatigue. Sometimes the patient may experience nausea, diarrhea, anemia and insomnia. Side Effects may vary from patient to patient depending upon the patient immune system. It is highly recommended taking doctor’s advice before taking the tablet. The doctor prescribed this medicine to you because he/ she know the benefits of this medicine and about your health.
How Generic Epclusa (Velpanat/Velasof) Effective for the Treatment of Hepatitis C
However generic Epclusa Sofosbuvir and Velpatasvir as much effective to treat in all genotype 1 to 6. But in certain cases, generic Epclusa is not necessary to take. The first generation hepatitis c drugs can treat, like if you have genotype 1 or 2 then it is not necessary to take generic Epclusa (Velpanat or Velasof) instead of this you can take Sofosbuvir+Daclatasvir.
The cost is low when compared to US Epclusa. The chances of cure are 100%. The cost of US Epclusa is around $74, 760 of 12 week treatment which is very expensive than the Indian generic medicine. As per World Health Organization, 1 million people have recovered from the chronic disease after accessing generic direct acting anti-viral medicines. This medicine rate is affordable so that the patient with all range income can buy this medicine.
How can buy Natco Velpanat or Hetero Velasof medicine from India?
Natco Velpanat and Hetero Velasof both are prescription drug that can be purchased only if the patient has a valid prescription by the physician or hepatologist. People all around the world can buy Velpanet tablet anywhere from India. Patients can also get Velasof/Velpanat medicine via online booking through trusted suppliers.
Velpanat/Velasof prices can be affordable in India.
The prices of both medicines are the same which is 100 times cheaper than the US medicines. So the patient who has the low income can also buy the medicine easily to cure the chronic disease.